Comparison of Screened and Nonscreened Breast Cancer Patients in Relation to Age: A 2-Institution Study

Barco, Israel; Chabrera, Carolina; Font, Marc García; Giménez, Núria; Fraile, Manel; Lain, J. M.; Piqueras, Mercè; Vidal, M.; Torras, María de los Ángeles Calvo; González, Sónia; Pessarrodona, Antoni; Barco, J; Cassadó, Jordi; García-Fernández, Antonio

doi:10.1016/j.clbc.2015.04.007

Cited by 16 publications

(14 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies investigating mortality in older patients with BC are scarce. Our data showed that overall and specific mortalities were higher when diagnosis was the result of CM.The same conclusions were made by Barco et al who also viewed mass screening as an improvement for women older than 69 years (23). Furthermore, differences of overall and disease-free survivals were both statistically as well as clinically significant.…”

Section: Discussionsupporting

confidence: 89%

Could Patients Older than 75 Years Benefit from a Systematic Breast Cancer Screening Program?

Ilenko¹,

Sergent²,

Mercuzot³

et al. 2017

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 89%

Could Patients Older than 75 Years Benefit from a Systematic Breast Cancer Screening Program?

Ilenko¹,

Sergent²,

Mercuzot³

et al. 2017

View full text Add to dashboard Cite

show abstract

“…3,4 In 2012, deaths from BC in the USA accounted for 783,000 years of potential life lost and an average of 19 years of life lost per death. 5 Early detection has been shown to be associated with reduced BC morbidity and mortality 6,7 and the goal of BC screening programs is to reduce both. Most BCs are detected due to clinical symptoms or by screening mammography (MMG).…”

Section: Introductionmentioning

confidence: 99%

MARIA M4: clinical evaluation of a prototype ultrawideband radar scanner for breast cancer detection

et al. 2016

View full text Add to dashboard Cite

Abstract. A microwave imaging system has been developed as a clinical diagnostic tool operating in the 3-to 8-GHz region using multistatic data collection. A total of 86 patients recruited from a symptomatic breast care clinic were scanned with a prototype design. The resultant three-dimensional images have been compared "blind" with available ultrasound and mammogram images to determine the detection rate. Images show the location of the strongest signal, and this corresponded in both older and younger women, with sensitivity of >74%, which was found to be maintained in dense breasts. The pathway from clinical prototype to clinical evaluation is outlined.

show abstract

“…Death rates for breast cancer have declined as a result of improvements in early detection and treatment . Multiple reports revealed reduction in mortality from breast cancer due to adoption of screening methods for detection of the disease at early stages . Early detection of breast cancer can be achieved through a combination of breast self‐examination (BSE), regular clinical breast examination (CBE) and mammography .…”

Section: Introductionmentioning

confidence: 99%

“…[1] Multiple reports revealed reduction in mortality from breast cancer due to adoption of screening methods for detection of the disease at early stages. [5][6][7][8][9] Early detection of breast cancer can be achieved through a combination of breast selfexamination (BSE), regular clinical breast examination (CBE) and mammography. [10,11] International screening recommendations best represented by the American Cancer Society (ACS) guidelines advocate a combination of BSE starting at the age of 20 years, regular CBE and annual mammography beginning at age 40 years for the early detection of breast cancer in average-risk women.…”

Section: Introductionmentioning

confidence: 99%

Knowledge, attitudes and barriers towards breast cancer health education among community pharmacists

Ayoub

Nuseir

Othman

et al. 2016

J Pharm Health Serv Res

View full text Add to dashboard Cite

Objectives The goal of this study was to evaluate knowledge, attitudes and perceived barriers among community pharmacists towards breast cancer health promotion. Methods A structured questionnaire was administered to 1000 registered community pharmacists in northern, central and southern regions in Jordan. Key findings Mean score for knowledge of breast cancer among community pharmacists was 8.51 AE 3.04 points out of 15 points, classifying the overall knowledge as acceptable. Five hundred (50%) pharmacists had poor knowledge, while the other half had acceptable level of knowledge for breast cancer. Mean score for pharmacists' knowledge of breast cancer screening was 3.83 AE 1.61 out of 7 points. Six hundred pharmacists (60%) had poor knowledge, while 400 pharmacists (40%) had satisfactory knowledge of screening guidelines. Pharmacists showed favourable attitude towards involvement in breast cancer education with an average score of 19.8 AE 4.35 out of 28 points. Lack of time was perceived by most pharmacists (63.9%) as a major barrier. Other highly recognised barriers were lack of privacy (57.1%) and lack of proper educational skills (56.2%). Age had no relationship with level of knowledge or attitude among pharmacists; however, a significant correlation exists between pharmacists' attitude and knowledge of breast cancer. Conclusions Knowledge of breast cancer and its screening were modest among community pharmacists in Jordan. However, views of community pharmacists towards breast cancer health promotion and awareness were positive. Efforts to improve knowledge of community pharmacists in order to be effective educators of the public about breast cancer are highly advocated.

show abstract

Comparison of Screened and Nonscreened Breast Cancer Patients in Relation to Age: A 2-Institution Study

Cited by 16 publications

References 42 publications

Could Patients Older than 75 Years Benefit from a Systematic Breast Cancer Screening Program?

Could Patients Older than 75 Years Benefit from a Systematic Breast Cancer Screening Program?

MARIA M4: clinical evaluation of a prototype ultrawideband radar scanner for breast cancer detection

Knowledge, attitudes and barriers towards breast cancer health education among community pharmacists

Contact Info

Product

Resources

About